Table 3.

GRADE summary of evidence for thrombolysis followed by AC vs AC alone in patients with massive PE

No. of studiesStudy designNo. of patients (%)EffectCertaintyImportance
Thrombolysis followed by ACAC aloneRelative (95% CI)Absolute (95% CI)
Mortality (assessed with: all-cause mortality) 
219,20  Nonrandomized studies 6/10 (50.0) 8/16 (50.0) RR, 0.88 (0.42-1.85) 60 fewer per 1000 (290 fewer to 425 more) ⊕○○○
Very low,  
Critical 
Thrombus recurrence 
119  Nonrandomized studies 3/7 (42.9) 3/15 (20.0) RR, 2.14 (0.57-8.09) 228 more per 1000 (86 fewer to 1000 more) ⊕○○○
Very low,  
Critical 
Bleeding (assessed with: unspecified bleed [intracranial/extracranial]) 
120  Nonrandomized studies 1/7 (14.3) 0/1 (0.0) Not estimable Not estimable ⊕○○○
Very low,  
Critical 
No. of studiesStudy designNo. of patients (%)EffectCertaintyImportance
Thrombolysis followed by ACAC aloneRelative (95% CI)Absolute (95% CI)
Mortality (assessed with: all-cause mortality) 
219,20  Nonrandomized studies 6/10 (50.0) 8/16 (50.0) RR, 0.88 (0.42-1.85) 60 fewer per 1000 (290 fewer to 425 more) ⊕○○○
Very low,  
Critical 
Thrombus recurrence 
119  Nonrandomized studies 3/7 (42.9) 3/15 (20.0) RR, 2.14 (0.57-8.09) 228 more per 1000 (86 fewer to 1000 more) ⊕○○○
Very low,  
Critical 
Bleeding (assessed with: unspecified bleed [intracranial/extracranial]) 
120  Nonrandomized studies 1/7 (14.3) 0/1 (0.0) Not estimable Not estimable ⊕○○○
Very low,  
Critical 

Risk of bias, assessed using ROBINS-I, was judged to be serious because of selection bias without adjustment for potential confounders.

Imprecision because of the small number of included patients and patients with events in the included studies.

or Create an Account

Close Modal
Close Modal